Non-cardiac surgery in patients with coronary stents: the RECO study

Albaladejo, Pierre; Marret, Emmanuel; Samama, Charles-Marc; Collet, Jean-Philippe; Abhay, Kou; Loutrel, Olivier; Charbonneau, Hélène; Jaber, Samir; Thoret, Sophie; Bosson, Jean-Luc; Piriou, Vincent
October 2011
Heart;Oct2011, Vol. 97 Issue 19, p1566
Academic Journal
Context Interruption or maintenance of oral antiplatelet therapy (OAT) during an invasive procedure may result in ischaemic and/or haemorrhagic complications. There is currently a lack of clear guidance regarding the issue of treatment interruption during surgical procedures. Objective To evaluate the rate of major adverse cardiac and cerebrovascular events (MACCEs) and major or minor bleeding complications and their associated independent correlates in coronary stented patients undergoing urgent or planned non-cardiac surgery. Design, setting, and patients Prospective, multicentre, observational cohort study of 1134 consecutive patients with coronary stents. Main outcome measures The co-primary endpoints consisted of the incidence of MACCE and major bleeding within the first 30 days of an invasive procedure. Results MACCE and haemorrhagic complications were observed in 124 (10.9%) and 108 (9.5%) patients, respectively, within an average time delay from invasive procedure to event of 3.3±3.9 and 5.3±5.3 days. Independent preoperative correlates for MACCE were complete OAT interruption for more than 5 days prior to surgery, preoperative haemoglobin <10 g/dl, creatinine clearance of <30 ml/min and emergency or high-risk surgery. Independent factors for haemorrhagic complications were preoperative haemoglobin <10 g/dl, creatinine clearance between 30 and 60 ml/min, a delay from stent implantation to surgery <3 months and high-risk surgery according to the Lee classification. Conclusions Patients with coronary stents undergoing an invasive procedure are at high risk of perioperative myocardial infarction including stent thrombosis irrespective of the stent type and major bleeding. Interruption of OAT more than 5 days prior to an invasive procedure is a key player for MACCE.


Related Articles

  • Duration of dual antiplatelet therapy after drug-eluting stent implantation: Meta-analysis of large randomised controlled trials. Tsoi, Man-Fung; Cheung, Ching-Lung; Cheung, Tommy Tsang; Wong, Ian Chi-Kei; Kumana, Cyrus Rustam; Tse, Hung-Fat; Cheung, Bernard Man-Yung // Scientific Reports;8/21/2015, p13204 

    Patients receive dual antiplatelet therapy (DAPT) for 6-12 months after drug-eluting stents (DES) implantation. The efficacy and safety of prolonged DAPT has been questioned. Therefore, we performed a meta-analysis on randomised trials comparing different DAPT durations. Literature was searched...

  • Anti-Platelet Therapy. Smyth, Susan S. // Current Drug Targets;Nov2011, Vol. 12 Issue 12, p1790 

    No abstract available.

  • Almanac 2013: acute coronary syndromes. Meier, Pascal; Lansky, Alexandra J.; Baumbach, Andreas // Wiener Klinische Wochenschrift;Mar2014, Vol. 126 Issue 5/6, p176 

    The article discusses the acute coronary syndrome (ACS) which is caused by the unstable coronary artery plaque and can lead to unstable angina, non-ST segment elevation infarction (NSTE-ACS), and ST elevation myocardial infarction (STEMI). Noted are decreased of ACS mortality due to therapeutic...

  • Prospective and Systematic Analysis of Unexpected Requests for Non-Cardiac Surgery or Other Invasive Procedures during the First Year after Drug-Eluting Stent Implantation. Byeong-Keuk Kim; Jung-Han Yoon; Dong-Ho Shin; Jung-Sun Kim; Young-Guk Ko; Donghoon Choi; Seung-Hwan Lee; Mintz, Gary S.; Yangsoo Jang; Myeong-Ki Hong // Yonsei Medical Journal;Mar2014, Vol. 55 Issue 2, p345 

    Purpose: Unexpected requests for non-cardiac surgery requiring discontinuation of dual antiplatelet therapy (DAPT) frequently occur in daily clinical practice. The objectives of this study were to evaluate prevalence, timing and clinical outcomes of such unexpected requests for non-cardiac...

  • Clinical investigation of transradial access for emergent percutaneous coronary intervention in patients with acute myocardial infarction. Xuguang Qin; Weiguo Xiong; Li Wang; Enben Guan; Chunpeng Lu // Clinical Interventions in Aging;Aug2013, Vol. 8, p1139 

    Background: Use of intensive anticoagulation and antiplatelet therapy in acute myocardial infarction (AMI) potentially increases the risk of bleeding complications during percutaneous coronary intervention via the transfemoral route. Recently, the transradial access has been intensively employed...

  • Effects of New Antiplatelet Agents and Aldosterone Receptor Antagonists on Mortality in Patients with Myocardial Infarction. Eyuboglu, Mehmet // Cardiovascular Drugs & Therapy;Oct2015, Vol. 29 Issue 5, p495 

    A letter to the editor is presented in response to the article "Effects of New Antiplatelet Agents and Aldosterone Receptor Antagonists on Mortality in Patients With Myocardial Infarction," that was published in the previous issue.

  • Delayed Left Ventricular Apical Thrombus Formation Following Discontinuation of Dual Anti-Platelet Therapy. Liou, Kevin; Lambros, John // Heart, Lung & Circulation;Nov2014, Vol. 23 Issue 11, pe237 

    Delayed de novo left ventricular apical thrombus following a distant antero-apical myocardial infarction has to our knowledge not been previously reported. Herein we describe a patient who developed an apical thrombus 18 months after his initial infarct following cessation of dual anti-platelet...

  • Role of Platelet Signaling in Thrombus Stabilization: Potential Therapeutic Implications. Saller, Fran�ois; Schapira, Marc; Angelillo-Scherrer, Anne // Current Signal Transduction Therapy;Jan2008, Vol. 3 Issue 1, p22 

    Platelets initiate arrest of bleeding at sites of vascular injury but also trigger inopportune arterial thrombosis, which causes heart attack and stroke. After formation of a single platelet monolayer at the site of injury, additional platelets are recruited into the growing hemostatic plug....

  • Improving Outcomes in STEMI PCI. Vinall, Maria // MD Conference Express;Oct2011, p13 

    The article focuses on the result of the study which examines the use of catheter-based thrombectomy to improve reperfusion and outcomes in patients with ST-segment elevation myocardial infarction (STEMI) who are treated with percutaneous coronary intervention (PCI). It shows that thrombectomy...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics